HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

At the closing of the transaction, the newly created combined entity will be named Hyperliquid Strategies Inc., which is ...

Sonnet BioTherapeutics merges to launch Hyperliquid Strategies, holding $888M in HYPE tokens and cash to build a leading ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

Bitcoin (BTC) is leading crypto markets to uncharted territory as four crypto treasury companies announce the acquisition of ...

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

Sonnet BioTherapeutics will transform into a new entity called HyperLiquid Strategies at the agreement's close. The new company is expected to hold 12.6 million HYPE tokens and gross cash invested of ...

The companies anticipate that the transaction will close in the coming months, subject to approval by authorities and ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Investor David Sacks, President Donald Trump 's artificial intelligence czar, is back in the spotlight after blasting the ...